Prediction of Patient Deterioration Using Machine Learning
- Conditions
- Chronic Obstructive Pulmonary DiseaseAsthmaGout FlareChronic Kidney DiseasesAnticoagulants; IncreasedInfectionAtrial Fibrillation RapidHeart FailureHypertensive Urgency
- Interventions
- Other: Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2
- Registration Number
- NCT05045742
- Lead Sponsor
- Brigham and Women's Hospital
- Brief Summary
This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict patient deterioration throughout a patient's admission. This algorithm was then validated in a validation cohort.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 500
Cared for in the Brigham and Women's Home Hospital study
Incomplete continuous monitoring data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Validation Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2 A subset of patients that are "held back" and used to validate the algorithm's accuracy. Training Traditional vital sign alarms versus the BioVitals Index vs the National Early Warning Score 2 A subset of patients that are used to train the machine learning algorithm.
- Primary Outcome Measures
Name Time Method Alarm burden From admission to discharge, measured in hours, on average 5 days The number of alarms fired per patient per hour
- Secondary Outcome Measures
Name Time Method Rate of alarms with clinical utility From admission to discharge, on average 5 days We will use general estimating equations (GEE) with three outcomes per patient (the number of clinically important alarms for BioVitals, NEWS2, and traditional vital signs); the GEE will account for the clustering between the three outcomes on a patient. The GEE will use a negative binomial marginal model with a log-link for the number of alarms with clinical utility and an offset for log length-of stay (in hours); with this model, we model the rate per hour of number of alarms with clinical utility with BI, NEWS2, and traditional vital signs. The main covariate in the negative binomial model will be a three-level covariate for method: BI vs NEWS2 vs traditional vital signs, and the exponential of the effect of this covariate will be a pair-wise rate ratio for BI vs NEWS2 vs traditional vital signs.
Specificity for recognition of a safety composite From admission to discharge, on average 5 days The specificity (true negatives divided by condition negatives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).
Positive predictive value for recognition of a safety composite From admission to discharge, on average 5 days The positive predictive value (true positives divided by the sum of true positives plus false positives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).
Sensitivity for recognition of a safety composite From admission to discharge, on average 5 days The sensitivity (true positives divided by condition positives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).
Negative predictive value for recognition of a safety composite From admission to discharge, on average 5 days The negative predictive value (true negatives divided by the sum of true negatives plus false negatives) for detection of a safety composite (overnight visit, extra unplanned visit, transfer back to the hospital, death during admission, delirium, loss of consciousness, or other major event).
Trial Locations
- Locations (2)
Brigham and Women's Faulkner Hospital
🇺🇸Boston, Massachusetts, United States
Brigham and Women's Hospital
🇺🇸Boston, Massachusetts, United States